Zobrazeno 1 - 3
of 3
pro vyhledávání: '"in vivo glucose-lowering activity"'
Autor:
Junyong Park, Mijeong Bak, Kiyoon Min, Hyun-Woo Kim, Jeong-Haeng Cho, Giyoong Tae, Inchan Kwon
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 263 (2021)
Glucagon-like peptide-1 (GLP-1) is a peptide hormone with tremendous therapeutic potential for treating type 2 diabetes mellitus. However, the short half-life of its native form is a significant drawback. We previously prolonged the plasma half-life
Externí odkaz:
https://doaj.org/article/c69c61edea3b48d9ab3e7c537a1c0278
Autor:
Kiyoon Min, Hyun-Woo Kim, Inchan Kwon, Junyong Park, Giyoong Tae, Jeong-Haeng Cho, Mijeong Bak
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 263, p 263 (2021)
Volume 13
Issue 2
Pharmaceutics, Vol 13, Iss 263, p 263 (2021)
Volume 13
Issue 2
Glucagon-like peptide-1 (GLP-1) is a peptide hormone with tremendous therapeutic potential for treating type 2 diabetes mellitus. However, the short half-life of its native form is a significant drawback. We previously prolonged the plasma half-life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5747d2d4240fdb582bc290b27058138
http://europepmc.org/articles/PMC7919490
http://europepmc.org/articles/PMC7919490
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.